Abstract
The appropriate animal model of diabetes mellitus type 2 is Zucker diabetic fatty (ZDF) rats. The goal of this study was to analyse the effect of chronic high-energy diet on diabetes mellitus (DM) complications in ZDF rats. Male ZDF rats (n = 20) and their lean controls (non-diabetic, n = 10) in the age of 3 months were involved in the experiment. Rats were provided with water and diet on ad libitum base. Animals were divided into three groups as follows: lean untreated rats (C) fed by KKZ-P/M (10 MJ/kg), obese rats fed by KKZ-P/M (10 MJ/kg, E1) and obese rats fed by enriched high energy diet (E2, enriched KKZ-P/M, 20 MJ/kg). Glucose, ketones levels, the consumption of feed, water and the live weight was measured weekly during the whole experiment. At the end of the experiment rats were anesthetized and selected haematological parameters were measured. ZDF rats in E1 and E2 group developed obesity, hyperglycaemia, non-insulin dependent diabetes, aggravations in haematological parameters and accumulation of sorbitol in sciatic nerve and lens of rats. High-energy diet immediately induced hyperglycaemia followed by accelerating the secondary symptoms of diabetes complications expressed by disturbed haematology parameters. High-energy diet caused ketoacidosis what meant two cases of death. Extended research on diabetes is needed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Akalin S, Berntorp K, Ceriello A, Das AK, Kilpatrick ES, Koblik T, Munichoodappa CS, Pan CY, Rosenthall W, Shestakova M, Wolnik B, Woo V, Yang WY, Yilmaz MT (2009) Global task force on glycaemic control. Intensive glucose therapy and clinical implications of recent data: a consensus statement from the global task force on glycaemic control. Int J Clin Pract 63:1421–1425. https://doi.org/10.1111/j.1742-1241.2009.02165.x
Akinsegun A, Akinola Olusola D, Sarah JO, Olajumoke O, Adewumi A, Majeed O, Anthonia O, Ebele U, Olaitan O, Olanrewaju A, Kingsley A (2014) Mean platelet volume and platelet counts in type 2 diabetes: mellitus on treatment and non-diabetic mellitus control in Lagos, Nigeria. Pan Afr Med J 18:42. https://doi.org/10.11604/pamj.2014.18.42.3651
Almind K, Kahn CR (2004) Genetic determinants of energy expenditure and insulin resistance in diet-induced obesity in mice. Diabetes 53:3274–3285. https://doi.org/10.2337/diabetes.53.12.3274
Amulic A, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A (2012) Neutrophil function: from mechanisms to disease. Annu Rev Immunol 30:459–489. https://doi.org/10.1146/annurev-immunol-020711-074942
Andrawus E, Veildbaum G, Zemel E, Leibu R, Perlman I, Shehadeh N (2017) Light modulates ocular complications in an albino rat model of type 1 diabetes mellitus. Trans Vis Sci Technol 6(4):1:1–1:113. https://doi.org/10.1167/tvst.6.4.1
Andrikopoulos S, Blair AR, Deluca N, Fam BC, Proietto J (2008) Evaluating the glucose tolerance test in mice. Am J Physiol Endocrinol Metab 295:E1323–E1332. https://doi.org/10.1152/ajpendo.90617.2008
Bain BJ, Lewis SM, Bates I (2001) Basic haematological techniques. In: Dacie and Lewis practical haematology, 9th edn, Churchill Livingstone, Edinburgh, pp 25–57. https://doi.org/10.1016/b0-44-306660-4/50007-6
Balazova L, Krskova K, Suski M, Sisovsky V, Hlavacova N, Olszanecki R, Jezova D, Zorad S (2016) Metabolic effects of subchronic peripheral oxytocin administration in lean and obese Zucker rats. J Physiol Pharmacol 67(4):531–541
Bielohuby M, Sisley S, Sandoval D, Herbach N, Zengin A, Fischereder M, Menhofer D, Stoehr BJM, Stemmer K, Wanke R, Tschöp MH, Seeley RJ, Bidlingmaier M (2013) Impaired glucose tolerance in rats fed low-carbohydrate, high-fat diets. Am J Physiol Endocrinol Metab 305:E1059–E1070. https://doi.org/10.1152/ajpendo.00208.2013
Bowe JE, Franklin ZJ, Hauge-Evans A, King AJ, Persaud SJ, Jones PM (2014) Assessing glucose homeostasis in rodent models. J Endocrinol 222:G13–G25. https://doi.org/10.1530/joe-14-0182
Citirik M, Beyazyildiz E, Simsek M, Beyazyildiz O, Haznedaroglu IC (2015) MPV may reflect subclinical platelet activation in diabetic patients with and without diabetic retinopathy. Eye 29(3):376–379. https://doi.org/10.1038/eye.2014.298
Corsetti JP, Sparks JD, Peterson RG, Smith RL, Sparks CE (2000) Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats. Atherosclerosis 148(2):231–241. https://doi.org/10.1016/s0021-9150(99)00265-8
Curtis TM, Gardiner TA, Stitt AW (2009) Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? Eye 23:1496–1508. https://doi.org/10.1038/eye.2009.108
Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M (2011) Global burden of metabolic risk factors of chronic diseases collaborating group (blood glucose). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378:31–40. https://doi.org/10.1016/s0140-6736(11)60679-x
Danis R, Yang Y (1993) Microvascular retinopathy in the Zucker diabetic fatty rat. Invest Ophthalmol Vis Sci 34(7):2367–2371
Davi G, Patrono C (2007) Platelet activation and atherothrombosis. N Engl J Med 357:2482–2494. https://doi.org/10.1056/nejmra071014
DeFronzo R (1988) The triumvirate: beta cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667–685. https://doi.org/10.2337/diab.37.6.667
Friedman EA, Friedman AL (2007) Is there really good news about pandemic diabetic nephropathy? Nephrol Dial Transplant 22:681–683. https://doi.org/10.1093/ndt/gfl735
Garnett KE, Chapman P, Chambers JA, Waddell I, Boam DSW (2005) Differential gene expression between Zucker fatty rats and Zucker diabetis fatty rats: a potential role for the immediate-early gene Egr-1 in regulation of beta cell proliferation. J Mol Endocrinol 35:13–25. https://doi.org/10.1677/jme.1.01792
Gault VA, Kerr BD, Harriott P, Flatt PR (2011) Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with type 2 diabetes and obesity. Clin Sci 121:107–117. https://doi.org/10.1042/cs20110006
Gavard JA, Lustman PJ, Clouse RE (1993) Prevalence of depression in adults with diabetes: an epidemiological evaluation. Diabetes Care 16(8):1167–1178. https://doi.org/10.2337/diacare.16.8.1167
Gheni G, Yokoi N, Beppu M, Yamaguchi T, Hidaka A, Hoshino Y, Hoshino M, Seino S (2015) Characterization of the prediabetic state in a novel rat model of type 2 diabetes, the ZFDM rat. J Diabetes Res 2015:1–8. https://doi.org/10.1155/2015/261418
Gkrania-Klotsas E, Ye Z, Cooper AJ, Sharp SJ, Luben R, Biggs ML, Chen LK, Gokulakrishnan K, Hanefeld M, Ingelsson E, Lai WA, Lin SY, Lind L, Lohsoonthorn V, Mohan V, Muscari A, Nilsson G, Ohrvik J, Qiang JC, Jenny NS, Tamakoshi K, Temelkova-Kurktschiev T, Wang YY, Yajnik CS, Zoli M, Khaw KT, Forouhi NG, Wareham NJ, Langenberg C (2010) Differential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies. PLoS One 5(10):e13405. https://doi.org/10.1371/journal.pone.0013405
Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE (2014) Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 103:137–149. https://doi.org/10.1016/j.diabres.2013.11.002
Hempe J, Elvert R, Schmidts HL, Kramer W, Herling AW (2012) Appropriateness of the Zucker diabetic fatty rata as a model for diabetis microvascular late complications. Lab Anim 46:32–39. https://doi.org/10.1258/la.2011.010165
Huang J, Xiao Y, Xu A, Zhou Z (2016) Neutrophils in type 1 diabetes. J Diabetes Investig 7:652–663. https://doi.org/10.1111/jdi.12469
Inzucchi SE, Sherwin RS (2005) The prevention of type 2 diabetes mellitus. Endocrinol Metab Clin N Am 34(1):199–219. https://doi.org/10.1016/j.ecl.2004.11.008
Ishii Y, Ohta T, Sasase T (2012) Non-obese type 2 diabetes animals models. InTechOpen:223–242. https://doi.org/10.5772/52712
Izumi Y, Ishibashi G, Nakanishi Y, Kikunaga S (2007) Beneficial effect of 3% milled-rice on blood glucose level and serum lipid concentrations in spontaneously non-insulin-dependent diabetic rats. J Nutr Sci Vitaminol (Tokyo) 53:400–409. https://doi.org/10.3177/jnsv.53.400
Jindal S, Gupta R, Gupta R, Kakkar A, Singh AV, Gupta K, Singh S (2011) Platelet indices in diabetes mellitus: indicators of diabetic microvascular complication. Hematology 16:86–89. https://doi.org/10.1179/102453311x12902908412110
Karasova MJ, Soltesova Prnova M, Stefek M (2014) A novel zwitterionic inhibitor of aldose reductase interferes with polyol pathway in ex vivo and in vivo models of diabetic complications. Pharmazie 69(10):747–751
Khandekar MM, Khurana AS, Deshmukh SD, Kakrani AL, Katdare AD, Inamdar AK (2006) Platelet volume indices in patients with coronary artery disease and acute myocardial infarction: an Indian scenario. J Clin Pathol 59:146–149. https://doi.org/10.1136/jcp.2004.025387
Kim J, Kim CS, Sohn E, Kim H, Jeong IH, Kim JS (2010) Lens epithelial cell apoptosis initiates diabetic cataractogenesis in the Zucker diabetic fatty rat. Graefes Arch Clin Exp Ophthalmol 248(6):811–816. https://doi.org/10.1007/s00417-010-1313-1
King AJF (2012) The use of animal models in diabetes research. Br J Pharmacol 166:877–894. https://doi.org/10.1111/j.1476-5381.2012.01911.x
Kraakman MJ, Lee MK, Al-Sharea A, Dragoljevic D, Barrett TJ, Montenont E, Basu D, Heywood S, Kammoun HL, Flynn M, Whillas A, Hanssen NM, Febbraio MA, Westein E, Fisher EA, Chin-Dusting J, Cooper ME, Berger JS, Goldberg IJ, Nagareddy PR, Murphy AJ (2017) Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes. J Clin Invest 127(6):2133–2147. https://doi.org/10.1172/jci92450
Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH (1994) Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci 91(23):10878–10882. https://doi.org/10.1073/pnas.91.23.10878
Leng SH, Lu FE, Xu LJ (2004) Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. Acta Pharmacol Sin 25(4):496–502
Li N, Hu H, Lindqvist M (2000) Platelet-leukocyte cross talk in whole blood. Arterioscler Thromb Vasc Biol 20:2702–2708. https://doi.org/10.1161/01.atv.20.12.2702
Lopez-Miranda J, Williams C, Lairon D (2007) Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism. Br J Nutr 98:458–473. https://doi.org/10.1017/s000711450774268x
Mahmoud AM (2013) Hematological alterations in diabetic rats – role of adipocytokines and effect of citrus flavonoids. EXCLI J 12:647–657
Matthews JNS, Altman DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. BMJ 300:230–235. https://doi.org/10.1136/bmj.300.6719.230
Miyake K, Yang W, Hara K, Yasuda K, Horikawa Y, Osawa H, Furuta H, Ng MC, Hirota Y, Mori H, Ido K, Yamagata K, Hinokio Y, Oka Y, Iwasaki N, Iwamoto Y, Yamada Y, Seino Y, Maegawa H, Kashiwagi A, Wang HY, Tanahashi T, Nakamura N, Takeda J, Maeda E, Yamamoto K, Tokunaga K, Ma RC, So WY, Chan JC, Kamatani N, Makino H, Nanjo K, Kadowaki T, Kasuga M (2009) Construction of a prediction model for type 2 diabetes mellitus in the Japanese population based on 11 genes with strong evidence of the association. J Hum Genet 54(4):236–241. https://doi.org/10.1038/jhg.2009.17
Mylari BL, Armento SJ, Beebe DA, Conn EL, Coutcher JB, Dina MS, O'Gorman MT, Linhares MC, Martin WH, Oates PJ, Tess DA, Withbroe GJ, Zembrowski WJ. (2003) A highly selective, non-hydantoin, non-carboxylic acid inhibitor of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3-methylbenzofuran- 2-sulfonyl)-2-H-pyridazin-3-one. J Med Chem 46:2283–2286. https://doi.org/10.1021/jm034065z
Nakhjavani M, Nargesi AA, Salabati M, Mahmoudzadeh R, Morteza A, Heidari B, Esteghamati A (2015) Changes in leukocyte subpopulations with decline in glomerular filtration rate in patients with type 2 diabetes. Acta Med Iran 53(7):425–431
Ohneda M, Inman LR, Unger RH (1995) Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta-cell GLUT 2 and glucose incompetence. Diabetologia 38:173–179. https://doi.org/10.1007/s001250050267
Oltman CL, Coppey LJ, Gellett JS, Davidson EP, Lund DD, Yorek MA (2005) Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats. Am J Physiol Endocrinol Metab 289(1):E113–E122. https://doi.org/10.1152/ajpendo.00594.2004
Oyedemi SO, Adewusi EA, Aiyegoro OA, Akinpelu DA (2011) Antidiabetic and haematological effect of aqueous extract of stem bark of Afzelia Africana (smith) on streptozocin-induced diabetic Wistar rats. Asian Pac J Trop Biomed 1(5):353–358. https://doi.org/10.1016/s2221-1691(11)60079-8
Park Y, Schoene N, Harris W (2002) Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 13(5–6):301–306. https://doi.org/10.1080/095371002220148332
Piwowar A, Knapik-Kordecka M, Warwas M (2000) Concentration of leukocyte elastase in plasma and polymorphonuclear neutrophil extracts in type 2 diabetes. Clin Chem Lab Med 38(12):1257–1261. https://doi.org/10.1515/cclm.2000.198
Pospisilik JA, Stafford SG, Demuth HU, Brownsey R, Parkhouse W, Finegood DT, McIntosh CHS, Pederson RA (2002) Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and β-cell glucose responsiveness in VDF (fa/fa) Zucker rats. Diabetes 51:943–950. https://doi.org/10.2337/diabetes.51.4.943
Ruggeri ZM (2002) Platelets in atherothrombosis. Nat Med 8:1227–1234. https://doi.org/10.1038/nm1102-1227
Schrauwen P, Westerterp KR (2000) The role of high-fat diets and physical activity in the regulation of body weight. Br J Nutr 84:417–427. https://doi.org/10.1017/s0007114500001720
Semple JW, Italiano JE Jr, Freedman J (2011) Platelets and the immune continuum. Nat Rev Immunol 11:264–274. https://doi.org/10.1038/nri2956
Shibata T, Takeuchi S, Yokota S, Kakimoto K, Yonemori F, Wakitani K (2000) Effects of peroxisome proliferator-activated receptor-alpha and-gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats. Br J Pharmacol 130:495–504. https://doi.org/10.1038/sj.bjp.0703328
Soltesova Prnova M, Ballekova J, Gajdosikova A, Gajdosik A, Stefek M (2015) A novel carboxymethylated mercaptotriazinoindole inhibitor of aldose reductase interferes with the polyol pathway in streptozotocin-induced diabetic rats. Physiol Res 64(4):587–591
Srivastava SK, Ramana KV, Bhatnagar A (2005) Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr Rev 26:380–392. https://doi.org/10.1210/er.2004-0028
Stefek M, Soltesova Prnova M, Ballekova J, Majekova M (2016) Cemtirestat, a novel aldose reductase inhibitor and antioxidant, in multitarget pharmacology of diabetic complications. Proceedings of Research World International Conference, Muscat, Oman, 20th May 2016
Stookey JD, Burg M, Sellmeyer DE, Greenleaf JE, Arieff A, Van Hove L, Gardner C, King JC (2006) A proposed method for assessing plasma hypertonicity in vivo. Eur J Clin Nutr 61:143–146. https://doi.org/10.1038/sj.ejcn.1602481
Tetikoglu M, Aktas S, Sagdik HM, Yigitoglu ST, Özcura F (2016) Mean platelet volume is associated with diabetic macular edema in patients with type-2 diabetes mellitus. Semin Ophthalmol 32(5):651–654. https://doi.org/10.3109/08820538.2016.1157612
Valle A, Giamporcaro GM, Scavini M, Stabilini A, Grogan P, Bianconi E, Sebastiani G, Masini M, Maugeri N, Porretti L, Bonfanti R, Meschi F, De Pellegrin M, Lesma A, Rossini S, Piemonti L, Marchetti P, Dotta F, Bosi E, Battaglia M (2013) Reduction of circulating neutrophils precedes and accompanies type 1 diabetes. Diabetes 62:2072–2077. https://doi.org/10.2337/db12-1345
Vinik AI, Erbas T, Park TS, Nolan R, Pittenger GL (2001) Platelet dysfunction in type 2 diabetes. Diabetes Care 24:1476–1485. https://doi.org/10.2337/diacare.24.8.1476
Winzell MS, Ahren B (2004) The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 54(Suppl 3):S215–S219. https://doi.org/10.2337/diabetes.53.suppl_3.s215
Yokio N, Hoshino M, Hidaka S, Yoshida E, Beppu M, Hoshikawa R, Sudo K, Kawada A, Takagi S, Seino S (2013) A novel rat model of type 2 diabetes: the Zucker fatty diabetes mellitus ZFDM rat. J Diabetes Res 103731, 9 pages. https://doi.org/10.1155/2013/103731
Acknowledgements
The authors express appreciation and thanks to all of the colleagues from Institute of Experimental Pharmacology and Toxicology of Slovak Academy of Sciences for their help, technical assistances and discussions. This study was supported by APVV grant no 15/0229.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
The experiment was approved by the Ethical committee and the State Veterinary and Food Administration of the Slovak Republic under the number 2288/16–221.
Conflicts of interest
There are no conflicts to declare.
Rights and permissions
About this article
Cite this article
Capcarova, M., Kalafova, A., Schwarzova, M. et al. The high-energy diet affecting development of diabetes symptoms in Zucker diabetic fatty rats. Biologia 73, 659–671 (2018). https://doi.org/10.2478/s11756-018-0076-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11756-018-0076-8